| Samrat Pharmachem Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 530125 |
NSE Symbol : - |
P/E(TTM) : 49.86 |
|
ISIN Demat : INE103E01016 |
Div & Yield% : 0.39 |
EPS(TTM) : 5.08 |
|
Book Value(₹) : 228.74 |
Market Cap(₹Cr) : 78.26 |
Face Value(₹) : 10.00 |
| Particulars | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | - | - | - | - | - |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 25.35 |
| Net Sales | 285.86 | 281.58 | 310.65 | 221.75 | 179.02 |
| Other Income | 0.97 | 1.38 | 0.48 | 0.63 | 0.46 |
| Stock Adjustments | 2.52 | -4.84 | 10.14 | 0.33 | -2.23 |
| Total Income | 289.35 | 278.12 | 321.27 | 222.71 | 177.25 |
| EXPENDITURE : | |||||
| Raw Materials | 269.27 | 265.48 | 288.00 | 190.23 | 162.02 |
| Power and Fuel Cost | 1.39 | 1.37 | 1.46 | 1.34 | 1.12 |
| Other Manufacturing Expenses | 2.28 | 2.04 | 2.47 | 2.29 | 1.65 |
| Selling and Administration Expenses | 3.38 | 3.62 | 3.10 | 2.46 | 1.83 |
| Miscellaneous Expenses | 0.70 | 0.66 | 0.76 | 0.55 | 0.47 |
| Employee Benefit Expenses | 1.11 | 1.11 | 1.07 | 0.96 | 1.05 |
| Less: Preoperative Expenditure | - | - | - | - | - |
| Total Expenses | - | - | - | - | - |
| Operating Profit | 11.21 | 3.86 | 24.40 | 24.87 | 9.12 |
| Interest | 0.67 | 0.69 | 1.23 | 0.67 | 1.28 |
| Gross Profit | 10.54 | 3.17 | 23.17 | 24.20 | 7.84 |
| Depreciation | 0.65 | 0.65 | 0.64 | 0.59 | 0.49 |
| Profit Before Tax | 9.89 | 2.52 | 22.53 | 23.61 | 7.35 |
| Current Tax | 3.00 | 0.28 | 6.11 | 6.39 | 1.72 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -0.23 | 0.08 | -0.21 | 0.03 | 0.29 |
| Reported Net Profit | 7.11 | 2.16 | 16.63 | 17.18 | 5.33 |
| Extraordinary Items | 0.22 | 0.89 | 0.00 | -0.02 | -0.01 |
| Adjusted Net Profit | 6.89 | 1.27 | 16.63 | 17.20 | 5.34 |
| Adjustment below Net Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit/Loss Balance carried down | 61.91 | 60.05 | 43.73 | 26.55 | 21.21 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 0.31 | 0.31 | 0.31 | 0.00 | 0.00 |
| P & L Balance carried down | 68.71 | 61.91 | 60.05 | 43.73 | 26.55 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 10.00 | 10.00 | 10.00 | 10.00 | 0.00 |
| Dividend Per Share(Rs) | 1.00 | 1.00 | 1.00 | 1.00 | 0.00 |
| Earnings Per Share-Unit Curr | 23.02 | 7.00 | 53.83 | 55.62 | 17.26 |
| Earnings Per Share(Adj)-Unit Curr | - | - | - | - | - |
| Book Value | 232.39 | 210.37 | 204.37 | 151.54 | 95.92 |
| Book Value(Adj)-Unit Curr | 232.39 | 210.37 | 204.37 | 151.54 | 95.92 |